Article
Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killing
2025-09-19
Abstract excerpt
Natural killer (NK) cell-based immunotherapies represent a promising avenue for cancer treatment due to their ability to eliminate cancer cells independently of antigen presentation and potential for “off-the-shelf” use. However, the molecular determinants governing tumor cell susceptibility to NK cell-mediated cytotoxicity remain incompletely understood. Here we employed CRISPR activation (CRISPRa) screening to s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2705f4a-48d0-5f52-9b00-895f6cfee79b
- DOI
- 10.1101/2025.09.17.676710
